The long-term colony formation assay in addition to the short-term cell proliferation assay demonstrated that andrographolide significantly promoted doxorubicin-induced cell death in cancer cells, showing that andrographolide improves the sensitivity of cancer cells to doxorubicin principally by means of STAT3 suppression. The gene discussed is STAT3; the disease is cancer.